Myeloproliferative Neoplasms (MPN)

M. Veronica Dioverti, M.D. is a Clinical Associate in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. She graduated from Universidad Nacional de Asuncion and completed her internship and residency training at Bridgeport Hospital-Yale University in Bridgeport, CT. She then pursued General and Transplant/Oncology Infectious Diseases fellowships at Mayo Clinic in Rochester, MN. Her primary clinical interest is caring for transplant, hematology/oncology malignancies and other immunocompromised patients. Her research has focused on optimizing the diagnosis of

Dr. Mojtaba Akhtari is a Hematologist/Oncologist with medical and hematology/oncology training and experience in the United Kingdom and United States of America. He is board certified in Internal Medicine, Hematology and Medical Oncology. Currently he is working at Loma Linda Cancer Center and University Hospital. He is the Chief of Adult Hematopietic Stem Cell Transplant. He was also a member of adult bone marrow transplantation team at UNMC in Omaha, NE, and USC in Los Angeles, CA. His interests include malignant hematological disorders, particularly acute and chronic leukemias as well as

General Director of Clínica Ruiz, Center of Hematology and Internal Medicine of Puebla; Director of research Division of Laboratorios Ruiz, within Clínica Ruiz; Professor of Hematology at the Autonomous Popular University of the State of Puebla

Hemant S. Murthy M.D., is a Hematology/Oncology physician, with specialty interest in BMT/CAR-T and acute leukemia practice. Dr. Murthy previously served as Assistant Professor of Medicine at the University of Florida College of Medicine in Gainesville, Florida. Prior to joining UF Health, Dr. Murthy was a transplant and cellular immunotherapy fellow at Moffitt Cancer Center.

The focus of Dr. Garcia's research is to develop novel proof-of-concept studies to gain insight on the underlying pathophysiology of acute leukemia and to identify biological predictors of response by partnering with Dana-Farber Cancer Institute laboratory investigators.

Dr. Traer completed a fellowship in hematology/oncology from Oregon Health & Science University. He received his M.D./Ph.D. from the University of Texas Southwestern Medical School and completed a residency in internal medicine at Oregon Health & Science University. In addition to practicing general hematology at OHSU Knight Cancer Institute, Dr. Traer is involved in clinical trials evaluating targeted therapy with kinase inhibitors in leukemia patients. He is performing research with Brian Druker, M.D. to investigate how the bone marrow microenvironment provides sanctuary to leukemia cells by